From blood samples routinely received for bovine viral diarrhea (BVD) diagnosis, 860 samples without antibodies to BVD virus were examined in both virus isolation and in an antigen-detecting enzymelinked immunosorbent assay (ELISA) based on monoclonal antibodies (MAbs) against the nonstructural BVD virus protein p125/p80. A total of 843 samples (98%) were positive (n= 170, 20%) or negative (n = 673, 78%) in both tests, corresponding to an agreement of K = 0.94. Among 17 samples with diverging results, 3 were from animals transiently infected with BVD virus, and 5 came from clinically affected animals. The reactivity of the MAbs was controlled against 387 field isolates of BVD virus. All were detected by the MAbs, thereby confirming the general view that the p125 virus protein is highly conserved among different BVD viruses.
Bovine viral diarrhea (BVD) virus is a small, enveloped single-stranded RNA virus causing economically important infections in cattle populations worldwide. 2 Of crucial importance in the epidemiology of BVD are persistently infected immunotolerant individuals, which by shedding large amounts of virus effectively transmit the infection to susceptible animals. 10 Although both attenuated and inactivated vaccines have been available, the side effects of the former 1 and insufficient immunity induced by the latter 17 reduce their value as sole efforts in control programs. Consequently, BVD vaccines are not registered in Norway, and attempts to control the spread of BVD virus (BVDV) infections are currently based on laboratory tests for identification of persistently infected animals.
Until recently, detection of virus in clinical samples has usually been done by virus isolation, thereby restricting this rather time-consuming test to laboratories with cell-culture facilities. Virus isolation protocols with shorter incubation periods have resulted in lower sensitivity, 15 thus leaving a maximal sensitivity virus isolation assay to a minimum of 5 days. During the last several years, several research groups have produced and characterized monoclonal antibodies (MAbs) reacting with BVDV antigens. 4, 5, 7, 9, 11, 12, 26, 30 Besides having provided essential information about the molecular biology of pestiviruses, several of these MAbs have qualities of importance in pestivirus diagnostic work. Anti-gp53 MAbs, which may neutralize BVDV, usually recognize only a limited number of BVDV isolates and have localized the site of antigenic diversity in BVDV to the major glycoprotein gp53. 4, 7, 30 Anti-gp53 MAbs are therefore less suited for BVDV routine diagnostic enzyme-linked immunosorbent assays (ELI-SAs), but because they usually do not bind to hog cholera virus (HCV), anti-gp53 MAb panels have been used successfully to discriminate BVDV from HCV infections in pigs. 25 Conversely MAbs specific for the nonstructural virus protein p125 (also expressed as p80 by cytopathogenic BVDVs) react with all or nearly all pestivirus isolates tested, including HCV. 6, 7, 11, 24 Because no recent information on antigenic diversity of Norwegian BVDV isolates is available, and because Norway is free from HCV, a test system based on detection of p125 is ideal.
In this article, we sum up our initial results with anti-p125 MAbs and an antigen-capture ELISA (AgELISA) for detection of BVDV-specific antigen in blood samples routinely submitted for BVD diagnosis.
Materials and methods
Blood samples. Practicing veterinarians seeking BVD diagnosis were asked to submit 10-ml heparinized blood samples. Upon receipt, the samples were centrifuged at 1,500 x g for 10 min, and plasma aliquots were screened for antibodies to BVDV with an ELISA kit. a A total of 866 samples without or with low antibody levels were included in this study, and from these the leucocyte fraction (buffy coat) was removed for viral antigen preparation, and blood plasma was used to inoculate cell cultures for virus isolation. The majority of the samples were taken from apparently healthy animals, but samples were also received from clinically affected animals, including confirmative samples from animals earlier found to be virus positive. Although the majority were received from the southwestern, southeastern, and central regions of Norway, samples were received from all parts of the country.
Virus isolation and immunostaining. The plasma samples were examined for BVDV in a cell culture/enzyme immu-noassay based on a described method. 20 Ninety-six-well microtiter plates with 1-2-day-old low-passage fetal calf kidney cell cultures were inoculated with 50 µl plasma in each of 4 parallel wells. After incubation for 4 days, the cells were fixed with 20% acetone in phosphate-buffered saline (PBS) and indirectly immunolabeled with an anti-pestivirus antibody followed by a corresponding horseradish peroxidase-labeled anti-immunoglobulin. Bound enzyme activity was visualized by incubation with H 2 O 2 and 3-amino-9-ethylcarbazole as substrate, and typically infected cells were scored by microscopic examination.
Antigen preparation. Viral antigens were extracted from peripheral white blood cells essentially as described. 13 The buffy coat was resuspended in ammonium chloride/Tris buffer (0.14 M NH 4 Cl, 0.17 M Tris, b pH 7.2) for lysis of erythrocytes. Following centrifugation (5 min at 3,000 x g), the leucocytes were washed twice by resuspending the pellet in 1.5-ml volumes of PBS. Soluble viral antigens were extracted by agitating the pellet in 1.5 ml 1% Nonidet P-40 b (in PBS) for 2 hr at room temperature. The antigen-containing supernatants were stored at -20 C until tested in the ELISA. As reference samples, antigen was prepared from leucocytes from known positive and negative animals and calibrated to give ELISA values equalling low positive and negative samples, respectively.
Antigen-capture ELISA. Four MAbs, c each recognizing a different epitope on the nonstructural pestivirus protein p125/ p80, had been selected for optimal antigen-capture efficiency. Two of the MAbs (VPM20 and VPM22, originally raised against a cytopathic Border disease virus isolate 11 ) had shown pan-pestivirus reactivity, whereas the other pair (13G4 and VPM12, raised against the NADL strain of BVDV) had reacted with more than 98% of pestivirus isolates tested (P. Nettleton, personal communication).
Ninety-six-well polystyrene microtiter plates d were coated with 2 of the MAbs (VPM20 and 13G4) by overnight incubation at 4 C with 100 µl/well of ascitic fluid MAbs (diluted 1:5,000 in a 50-mM carbonate buffer, pH 9.6). Subsequently, free binding sites were blocked by incubation with 10% horse serum diluted in PBS for 1 hr at 37 C. Between all following incubation steps the plates were washed 3 times with PBS containing 0.5% Tween 80 (PBST) (200 µl/well); all immunoreactants were added in 100-µ1 volumes/well, and the plates were sealed with adhesive plastic and incubated at 37 C. Test antigens and standardized control antigen preparations were added in four parallel wells and incubated for 2 hr. Two wells were incubated with a mixture of 2 horseradish peroxidase (PO)-labeled anti-p125 MAbs (VPM12-PO and VPM22-PO, each diluted 1:2,000 in PBST with 10% horse serum) and the other 2 wells were incubated with an irrelevant control conjugate (an anti-rotavirus MAb-PO). As substrate, a citrate/phosphate buffer (pH 5.0) containing o-phenylene-diamine (0.8 mg/ml) and H 2 O 2 (0.8 µl of a 30% solution/ml) was prepared immediately before use and incubated 10 min before being stopped with 50 µl 2.5 M H 2 SO 4 /well. Optical densities (OD) were read in a spectrophotometer e at 492 nm, and corrected OD values were calculated by subtracting mean OD with irrelevant conjugate from mean OD with specific conjugate.
Diagnostic sensitivity of MABs. To control the reported broad reactivity of MAbs specific for the nonstructural pestivirus protein p125 7,11,24 against Norwegian virus isolates, pairs of parallel cell culture wells inoculated with plasma were immunolabeled with two different sets of antibodies. One pair of parallel wells was incubated with a mixture of MAbs VPM20 and 13G4 followed by a PO-labeled rabbit anti-mouse Ig. 8 The other pair was incubated with hyperimmune serum from a calf (D5/85) repeatedly inoculated with several ruminant pestivirus strains (NADL, Oregon C24 plus 4 English and 10 Norwegian field isolates), 18 followed by a PO-labeled rabbit anti-bovine Ig. 8 Because the nonstructural protein p125 is one of the most conserved of the major antigens of pestiviruses, 6 this comparison was extended beyond the number of samples examined with both AgELISA and virus isolation to test a maximal number of BVDV field isolates. Statistical analysis. Values for sensitivity and specificity as well as measurement of agreement of the 2 tests were calculated according to described methods. 19 Because previous results from BVD diagnosis indicated that the majority of the samples to be tested in the AgELISA would be negative, the OD values of presumed negative test samples were used for calculation of cutoff values for each set of simultaneously processed AgELISA plates. Test samples with OD values lower than 25% of the positive control value were initially considered negative, and the mean (± SD) OD of these samples were used to calculate positive cutoff levels. 23 Different cutoff levels were evaluated by comparing the resulting values for sensitivity and specificity of the AgELISA.
Results
Virus isolation. Six of the blood samples were toxic for the cell cultures, leaving 860 samples examined with both tests. Of these, 18 samples were initially scored as inconclusive and had to be retested in cell cultures to give a definitive diagnosis. A total of 179 of 860 samples were positive in the cell culture immunoassay.
Antigen ELISA and comparison with virus isolation. On 22 different sets of AgELISA plates, the positive and negative control antigens gave OD values in the range 0.35-1.76 (median = 0.79) and 0-0.26 (median = 0.06), respectively. On each set of AgELISA plates, the OD levels of the control antigens and the mean OD of negative samples were positively correlated, indicating variation in the reaction conditions between AgELISA plates processed at different times. For each set of simultaneously processed AgELISA plates, the negative samples formed a narrow peak at low OD levels. In Fig. 1 , the frequency distribution of test sample OD values from AgELISA plates with nearly equal mean OD of AgELISA negative samples is shown. The OD values of antigen positive samples were distributed over a wider range, with a smaller peak centered around 3.5, representing a saturation plateau of the AgELISA. This pattern is also evident in Fig. 2 , in which the OD values of all samples positive in virus isolation is shown.
Of 27 samples positive in both AgELISA and virus isolation, but with AgELISA OD values below 1.0, second confirmative samples were received from 8 animals. The confirmative samples had OD values between 0.77 and 3.20 (median = 2.0; 2 samples were still below 1.0), whereas the initial OD values were 0.24-0.99 (median = 0.60).
Optimal values for the sensitivity and specificity of the AgELISA were obtained with positive cutoff levels 3 SDs above mean OD of presumed negative samples (Table 1) . With this cutoff level, the calculated OD cutoff values ranged from 0.07 to 0.51 (median = 0.125). Cutoff levels 2 or 5 SDs above mean OD of presumed negative samples resulted in AgELISA false positives or negatives, respectively, but the difference in numbers of positives with the 2 tests was only significant with a cutoff at 2 SDs above mean OD. As shown in Table 1 , the optimal cutoff level gave 170 positive and 673 negative samples with both tests, corresponding to an agreement of K = 0.94. With reference to virus isolation, the sensitivity and specificity of the AgELISA was 95.0% and 98.8%, respectively.
From 17 animals giving diverging results with the 2 tests, a second confirmative blood sample was received from 7 animals. As shown in Table 2 , three previously AgELISA negative and virus isolation positive animals were then antibody positive, indicating a transient virus infection when the first blood samples were drawn. This indicates that the AgELISA may selectively detect persistently infected animals. If the epidemiologic evaluation of the AgELISA is corrected for this, the sensitivity of the AgELISA increases to 96.6%.
Information on the clinical condition was available for 5 of the 17 animals with initially diverging test results. Two of these animals had clinical signs of mucosal disease, and both were initially AgELISA negative. One of these samples caused a cytopathic effect in the cell cultures, interfering with a clear positive diagnosis. After passage in cell culture tubes, a positive immunostaining diagnosis was verified, and the cell culture supernatant also tested positively in the Ag-ELISA. The confirmative sample received from the second case was positive in both tests. Three other samples, which had been drawn from 2 stillborn calves and a heifer with recurrent diarrhea, were AgELISA positive with low OD values. A second, also antibodynegative blood sample from the heifer reacted negatively in the AgELISA as well as in virus isolation.
Diagnosticsensitivity of MAbs.
A total of 3,326 samples were immunostained with both immune serum and MAbs. Because of ambiguous results, 52 samples (1.6%) were retested, leaving 384 samples positive and 2,939 samples negative with both sets of detecting antibodies (Table 3) . From these numbers, the degree of agreement of the 2 immunostaining procedures was calculated to be K = 0.996. Two virus isolates were detected only with the MAbs, but virus was detected only with the immune serum in 1 sample. Both virus isolates detected only with MAbs were seen as foci of typically infected cells in 1 of 4 parallel wells on both occasions. The leucocyte antigen preparation from the blood sample only immunostained with the immune serum was one of the samples which were positive in the AgELISA; thus all detected virus isolates were identified with the MAbs.
Generally, it was easier to recognize virus-infected cells in cultures immunostained with the MAbs than with the immune serum, mostly because of lower nonspecific background staining of uninfected cells. Although the staining intensity of virus-positive cells varied slightly between plates immunostained at different times, no such difference could be ascribed to different BVDV isolates with the MAbs or with the immune serum. The diverging results initially observed with 1.6% of the samples could grossly be classified into 2 categories: false readings caused by uneven or unspecific immunostaining (most frequently seen with the immune serum) and occurrence of partly infected cell cultures probably due to samples with low virus titers, which were randomly detected with 1 of the 2 staining procedures. 
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Discussion
Several MAbs specific for pestivirus proteins have been produced and characterized, and with few exceptions only anti-p125 MAbs have reacted with all pestiviruses. 5, 11, 24 The reactivity of anti-BVDV MAbs should be considered as an indication of the function of the virus protein in question. In contrast to the envelope glycoproteins, which are subject to immunologic selective pressure, 7 mutations of p125 are probably limited by the dependence of the enzyme functions of this protein. 29 The results of MAb binding studies also support data obtained from sequencing of different BVDV genomes, where the deduced amino acid sequences of BVDV strains NADL and Osloss for viral proteins gp53 and p80 were found to be 78.5% and 96.3% homologous, respectively. 6 BVDV may infect swine naturally and interfere with HCV diagnosis 25 Although HCV has been transmitted to cattle . experimentally, 8 HCV does not seem to infect ruminants naturally and is therefore unlikely to interfere with detection of BVDV p125-antigen in cattle blood samples. All 387 BVDV isolates detected in cell cultures were also identified with the MAbs. These results are in accordance with earlier work reporting broad reactivity of MAbs directed against the pestivirus nonstructural protein p125 7, 11, 24 and verifies further studies showing a 100% reactivity of the 2 pairs of MAbs against all tested pestivirus strains and isolates (P. Nettleton, personal communication).
According to the evaluation of kappa statistics for measurement of agreement of diagnostic tests, the present results indicate an excellent agreement between the results obtained with AgELISA and virus isolation. Nevertheless, 2% of the samples produced diverging results with the 2 tests. Because the purpose of identifying persistently infected animals is to avoid further infection of susceptible animals, false-negative results are potentially most dangerous. Therefore, special attention should be focused on conditions causing falsenegative AgELISA results. Although information on the clinical conditions of the animals was received occasionally, several of the samples giving low positive OD values or a false-negative AgELISA results originated from animals with clinical symptoms of mucosal disease. Leucopenia has been described in the early stages of mucosal disease 2 and may explain low or negative AgELISA values when viral antigen is extracted from the buffy coat. Our findings support those of a previous report indicating lower and more variable AgELISA values from cattle with suspected mucosal disease than from apparently healthy animals. 14 However, false-negative AgELISA results may also result from technical problems during the antigen preparation. When performed on a large scale, this procedure is rather labor intensive, and leucocyte aggregates can accidentally be lost during the washing steps. As concerns the samples positive in AgELISA and negative in virus isolation, available data on the sensitivity of virus isolation procedures suggest that these samples were false negative virus isolation results. It has been shown that virus isolation protocols using cell cultures cocultivated with washed leucocytes 15 or inoculated with blood clots 3 are more sensitive than those in which cell cultures are inoculated with serum. An incidental observation suggesting a negative correlation between virus titer in serum and level of antigen in leucocytes 16 supports possible occurrence of antigen-positive and virus-isolation-negative samples. Although broad reactivity of anti-pestivirus MAbs have been verified against numerous virus strains and isolates, little information on possible cross-reactions with other agents is available. An obvious advantage of an AgELISA using MAbs Our findings of high maximal OD values (> 3.6) of for both capture and detection of antigen is the avoidance of immune sera, which may cause batch-to-batch variations in performance of the assay. 13, 14, 16, 27 A double MAb AgELISA has been described, 21 but despite use of biotinylated MAbs and enzyme-labeled streptavidin for amplification of the color intensity, the substrate was incubated for 8 hours when the ELISA was evaluated for routine use. 22 With the described Ag-ELISA, the high OD obtained for positive samples indicates that the high affinity of the directly enzymelabeled MAbs have not been reduced by the conjugation process. In another study, variations in the level of viral antigens in peripheral blood leucocytes from persistently infected adult cattle has also been demonstrated. 28 Initially, ELISA cutoff levels were based on the OD values of reference antigen preparations from known positive and negative animals. Because the OD values of the positive reference antigen tended to vary more than expected between different ELISA plates, cutoff values were calculated from the OD values of presumed negative samples on each set of simultaneously processed ELISA plates. By using the statistical information of the currently investigated negative samples, a more representative negative reference population could be used, allowing more accurate cutoff levels than a negative reference sample would allow. 23 Further observations of the stability of the p125 antigen indicated that the reactivity of the MAbs decreased significantly when prepared antigen was stored at room temperature (results not shown). Whether this decrease is caused by the reported protease activity of the p125 protein 29 or by the activity of cellular factors We thank Dr. P. F. Nettleton for valuable comments on the reactivity of the monoclonal antibodies and guidelines for the performance of the antigen ELISA. remains to be seen. To avoid denaturation of the antigen, samples to be examined with anti-p125 antibodies should be stored below -20 C.
Sources and manufacturers
Previously, BVD diagnostic work has usually been complicated by contamination of cell cultures and reagents with virus or specific antibodies, necessitating careful monitoring of the test system. A major advantage of the AgELISA is the independence of cell cultures, making a rapid diagnosis from a local laboratory possible apparently without reduced fidelity. If the eventual ability to selectively detect persistently infected animals can be confirmed, the antigen ELISA would represent a further advantage over virus isolation.
